Carisoprodol 350mg Tablet Franchise in Ahmedabad

Muscle Relaxant Medicine Supplier in Bangalore

Pain Relief Tablet Distributor in Hyderabad

Musculoskeletal Disorder Tablet Franchise Opportunity in Jaipur

Muscle Spasm Relief Tablet Stockist in Mumbai
Carisoprodol 350mg Tablet Export & Manufacturing in Chandigarh

Home/Products /carisoprodol-350mg-tablet

Cariprol 350 Tablet

Composition : Carisoprodol (350mg) Tablet

Dosage Form : Tablet

Packaging Type : Blister

Packaging : 10*10

Price : ₹1/-

Cariprol 350 Tablet contains Carisoprodol 350mg, a widely used muscle relaxant that helps in relieving musculoskeletal pain, stiffness, and muscle spasms. It acts centrally on the nervous system to relax muscles, providing patients with rapid relief from discomfort associated with strains, sprains, and other musculoskeletal conditions.

The formulation ensures quick absorption and effective action, improving mobility and reducing pain, which enhances patient quality of life. It is commonly prescribed alongside physical therapy and analgesics for comprehensive musculoskeletal care, making it a valuable medicine in orthopedic and rehabilitation settings.

For distributors and resellers, Cariprol 350 Tablet is a high-demand pain management product, regularly required in hospitals, physiotherapy centers, orthopedic clinics, and general healthcare facilities. Its consistent prescription in both acute and chronic muscle pain scenarios ensures steady demand throughout the year.

Adding Cariprol 350 Tablet to your product range strengthens your muscle relaxant and pain-care portfolio, creating opportunities for bulk institutional supply, hospital tie-ups, government orders, export markets, and third-party manufacturing. Its essential role in musculoskeletal care makes it a profitable and strategically important product for any medical distributor.


Read More

About the Product

Cariprol 350 Tablet contains Carisoprodol 350mg, a widely used muscle relaxant that helps in relieving musculoskeletal pain, stiffness, and muscle spasms. It acts centrally on the nervous system to relax muscles, providing patients with rapid relief from discomfort associated with strains, sprains, and other musculoskeletal conditions.

The formulation ensures quick absorption and effective action, improving mobility and reducing pain, which enhances patient quality of life. It is commonly prescribed alongside physical therapy and analgesics for comprehensive musculoskeletal care, making it a valuable medicine in orthopedic and rehabilitation settings.

For distributors and resellers, Cariprol 350 Tablet is a high-demand pain management product, regularly required in hospitals, physiotherapy centers, orthopedic clinics, and general healthcare facilities. Its consistent prescription in both acute and chronic muscle pain scenarios ensures steady demand throughout the year.

Adding Cariprol 350 Tablet to your product range strengthens your muscle relaxant and pain-care portfolio, creating opportunities for bulk institutional supply, hospital tie-ups, government orders, export markets, and third-party manufacturing. Its essential role in musculoskeletal care makes it a profitable and strategically important product for any medical distributor.


Some patients may experience dizziness, drowsiness, headache, or nausea. Rarely, allergic reactions, dependence, or abnormal liver function may occur.

It is indicated for the short-term relief of acute musculoskeletal pain, muscle spasms, and associated discomfort. It helps improve mobility and supports physical therapy in patients with muscle injuries or strains.

Use only under medical supervision. Avoid operating machinery or driving while under the effect of this medicine. Not recommended for patients with a history of drug dependence or hypersensitivity to carisoprodol. Take as prescribed and do not exceed the recommended duration.

Store in a cool, dry place below 25°C, protected from light and moisture. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Strategic Advisory

Ms. Shiwani Dhiman

VP-Strategic Outreach & Engagement

Ms. Shiwani specializes in market outreach and strategic partnership orchestration for entrepreneurs building scalable PCD Pharma Franchise models.

View Professional Profile

Start Your Journey

Partner With Cafoli

Ready to Dominate your territory with a Monopoly-Based PCD Franchise? Join our rapidly growing network of successful franchise partners and turn your ambitions into reality. Limited Territories Available — Don’t Miss Out!

Quick Navigation